Strategic advisory services on both the buy and sell side

Healthcare and Life sciences is a highly attractive market for early-stage and private equity (PE) investors due to its robust underlying market growth, deep innovation potential and the existence of some highly profitable niche players in the sector.

Exploring potential

In the immediate aftermath of the pandemic, companies’ valuations reached a peak and the number of transactions was extremely high. As activity returns to more normal levels, assessing target opportunities during the transaction process requires in-depth and timely strategic analysis. In other words, investors must make an in-depth, strategic assessment of opportunities before striking a deal. This is where Vintura’s specialist Healthcare & Life Sciences Investment Advisory Services come into their own.

Whichever side you’re on, we have you covered

We provide specialist Healthcare and Life Sciences strategic advisory services on both the buy and sell side. Our deeply experienced senior team and global market coverage can provide highly-targeted guidance to private equity investors, as well as to strategic corporate teams and their merger and acquisition intermediaries, as they review next opportunities.
With a rapid turnaround, we provide strong and deep market insight for PE investors and management teams to provide strategic insights and minimize investor risk, with comprehensive yet highly digestible reports that ensure an edge in competitive situations.

Assessing opportunities

As activity returns to more normal levels, assessing target opportunities during the transaction process requires in-depth and timely strategic analysis. In other words, investors must make an in-depth, strategic assessment of opportunities before striking a deal. This is where Vintura’s specialist Healthcare & Life Sciences Investment Advisory Services come into their own.

Local attention, global coverage

Our projects extend right across the globe, with local presence throughout Europe, the US, China and Japan, resourced by an extensive senior team – made up entirely of Healthcare & Life Sciences industry specialists.

Access to an extensive network

Our concentrated focus on Healthcare and Life Sciences means that, in addition to an unrivaled track record in related deals and dossiers, we are connected to a vast, deep network of stakeholders across the industry globally (healthcare professionals, key opinion leaders, industry, regulatory experts, and more.)